Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency
- PMID: 26761946
- PMCID: PMC5096479
- DOI: 10.4274/jcrpe.2495
Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency
Abstract
Objective: Deficiency of steroid 5-alpha reductase type 2 (5αRD2) is a rare autosomal recessive disorder caused by mutations in the SRD5A2 gene. A defect in the 5-alpha reductase enzyme, which ensures conversion of testosterone into dihydrotestosterone, leads to disorders of sex development. This study presents the clinical and genetic results of patients with 5αRD2 deficiency.
Methods: 5αRD2 deficiency was detected in 6 different patients from 3 unrelated families. All patients were reared as girls. Two of the patients presented with primary amenorrhea, one with primary amenorrhea and rejection of female gender, and the others with masses in their inguinal canals. Chromosome and sex-determining region Y (SRY) gene analyses were performed in all patients. Additionally, five exons of the SRD5A2 gene were amplified with polymerase chain reaction in the obtained DNA samples and evaluated.
Results: While 46,XY was identified in 5 patients, 47,XXY was detected in one patient. The SRY gene was positive in all patients. The p.Ala65Pro (c193G>C) mutation and V89L polymorphism were observed in exon 1 of the SRD5A2 gene in all patients.
Conclusion: Identification of this mutation and polymorphism is a significant indicator of presence of 5αRD2 deficiency in Southeastern Turkey, a geographical region where consanguineous marriages are also highly common.
Figures



Similar articles
-
Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.J Clin Endocrinol Metab. 2011 Feb;96(2):296-307. doi: 10.1210/jc.2010-1024. Epub 2010 Dec 8. J Clin Endocrinol Metab. 2011. PMID: 21147889
-
Phenotype, genotype and gender identity in a large cohort of patients from India with 5α-reductase 2 deficiency.Andrology. 2015 Nov;3(6):1132-9. doi: 10.1111/andr.12108. Epub 2015 Oct 9. Andrology. 2015. PMID: 26453174
-
Genetic analysis of the SRD5A2 gene in Indian patients with 5alpha-reductase deficiency.J Pediatr Endocrinol Metab. 2009 Mar;22(3):247-54. doi: 10.1515/jpem.2009.22.3.247. J Pediatr Endocrinol Metab. 2009. PMID: 19492581
-
[The importance of DNA analysis in the diagnosis of steroid 5-alpha-reductase deficiency].Ginekol Pol. 1994 Jul;65(7):400-6. Ginekol Pol. 1994. PMID: 8001864 Review. Polish.
-
Diagnosis of 5α-reductase 2 deficiency: is measurement of dihydrotestosterone essential?Clin Chem. 2013 May;59(5):798-806. doi: 10.1373/clinchem.2012.196501. Epub 2013 Mar 19. Clin Chem. 2013. PMID: 23513070 Review.
Cited by
-
Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study.Front Pharmacol. 2019 Mar 15;10:173. doi: 10.3389/fphar.2019.00173. eCollection 2019. Front Pharmacol. 2019. PMID: 30930770 Free PMC article.
-
Genotype-phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: a multicenter study from Turkey.J Endocrinol Invest. 2019 Apr;42(4):453-470. doi: 10.1007/s40618-018-0940-y. Epub 2018 Aug 21. J Endocrinol Invest. 2019. PMID: 30132287
References
-
- Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol. 2002;198:51–59. - PubMed
-
- Cheon CK. Practical approach to steroid 5 alpha-reductase type 2 deficiency. Eur J Pediatr. 2011;170:1–8. - PubMed
-
- Gils CH, Onland-Moret NC, Roest M, Noord PA, van, Peeters PH. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:1194–1199. - PubMed
-
- Ko JM, Cheon CK, Kim GH, Kim SH, Kim KS, Yoo HW. Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5alpha-reductase type 2 deficiency. Horm Res Paediatr. 2010;73:41–48. - PubMed
-
- Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 1974;291:944–999. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources